Needham has recently reiterated Day One Biopharmaceuticals Inc (DAWN) stock to Buy rating, as announced on October 9, 2024, according to Finviz. Earlier, on August 1, 2024, BofA Securities had raised ...

Legend Biotech Corporation (NASDAQ:LEGN) is a clinical-stage company that develops, discovers, manufactures, and ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Select Fund” fourth quarter 2024 investor letter. A copy ...